Mostrar el registro sencillo del ítem

dc.contributor.authorCano, A.
dc.contributor.authorAlcalde, C.
dc.contributor.authorBelanger-Quintana, A.
dc.contributor.authorCañedo-Villarroya, E.
dc.contributor.authorCeberio, L.
dc.contributor.authorChumillas-Calzada, S.
dc.contributor.authorCorrecher, P.
dc.contributor.authorCouce Pico, María Luz
dc.contributor.authorGarcía-Arenas, D.
dc.contributor.authorGómez, I.
dc.contributor.authorHernández, T.
dc.contributor.authorIzquierdo-García, E.
dc.contributor.authorChicano, D.M.
dc.contributor.authorMorales, M.
dc.contributor.authorPedrón-Giner, C.
dc.contributor.authorJáuregui, E.P.
dc.contributor.authorPeña-Quintana, L.
dc.contributor.authorSánchez Pintos, Paula 
dc.contributor.authorSerrano-Nieto, J.
dc.contributor.authorSuarez, M.U.
dc.contributor.authorMiñana, I.V.
dc.contributor.authorde las Heras, J.
dc.date.accessioned2025-08-26T08:50:15Z
dc.date.available2025-08-26T08:50:15Z
dc.date.issued2022
dc.identifier.citationCano A, Alcalde C, Belanger-Quintana A, Cañedo-Villarroya E, Ceberio L, Chumillas-Calzada S, et al. Vitamin C and folate status in hereditary fructose intolerance. European Journal of Clinical Nutrition. 2022;76(12):1733-9.
dc.identifier.issn1476-5640
dc.identifier.otherhttps://portalcientifico.sergas.gal/documentos/62e5c2ede5f0e01a6a1d02fd*
dc.identifier.urihttp://hdl.handle.net/20.500.11940/20624
dc.description.abstractBackground: Hereditary fructose intolerance (HFI) is a rare inborn error of fructose metabolism caused by the deficiency of aldolase B. Since treatment consists of a fructose-, sucrose- and sorbitol-restrictive diet for life, patients are at risk of presenting vitamin deficiencies. Although there is no published data on the status of these vitamins in HFI patients, supplementation with vitamin C and folic acid is common. Therefore, the aim of this study was to assess vitamin C and folate status and supplementation practices in a nationwide cohort of HFI patients. Methods: Vitamin C and folic acid dietary intake, supplementation and circulating levels were assessed in 32 HFI patients and 32 age- and sex-matched healthy controls. Results: Most of the HFI participants presented vitamin C (96.7%) and folate (90%) dietary intake below the recommended population reference intake. Up to 69% received vitamin C and 50% folic acid supplementation. Among HFI patients, 15.6% presented vitamin C and 3.1% folate deficiency. The amount of vitamin C supplementation and plasma levels correlated positively (R = 0.443; p = 0.011). Interestingly, a higher percentage of non-supplemented HFI patients were vitamin C deficient when compared to supplemented HFI patients (30% vs. 9.1%; p = 0.01) and to healthy controls (30% vs. 3.1%; p < 0.001). Conclusions: Our results provide evidence for the first time supporting vitamin C supplementation in HFI. There is great heterogeneity in vitamin supplementation practices and, despite follow-up at specialised centres, vitamin C deficiency is common. Further research is warranted to establish optimal doses of vitamin C and the need for folic acid supplementation in HFI.en
dc.description.sponsorshipThis work was supported by Exp. No. 2018111095, Basque Government, Health Department; FEDER, the Spanish Federation for Rare Diseases (FI18053); and DanoneNutricia-Metabolics, which was not involved in the study hypothesis/design, execution, analysis, or interpretation.en
dc.language.isoeng
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.titleVitamin C and folate status in hereditary fructose intolerance*
dc.typeArticleen
dc.authorsophosCano, J. A.
dc.authorsophosAlcalde, C.
dc.authorsophosBelanger-Quintana, A.
dc.authorsophosCañedo-Villarroya, E.
dc.authorsophosCeberio, L.
dc.authorsophosChumillas-Calzada, S.
dc.authorsophosCorrecher, P.
dc.authorsophosCouce, M. L.
dc.authorsophosGarcía-Arenas, D.
dc.authorsophosGómez, I.
dc.authorsophosHernández, T.
dc.authorsophosIzquierdo-García, E.
dc.authorsophosChicano, D. M.
dc.authorsophosMorales, M.
dc.authorsophosPedrón-Giner, C.
dc.authorsophosJáuregui, E. P.
dc.authorsophosPeña-Quintana, L.
dc.authorsophosSánchez-Pintos, P.
dc.authorsophosSerrano-Nieto, J.
dc.authorsophosSuarez, M. U.
dc.authorsophosMiñana, I. V.
dc.authorsophosde las, Heras
dc.identifier.doi10.1038/s41430-022-01178-3
dc.identifier.sophos62e5c2ede5f0e01a6a1d02fd
dc.issue.number12
dc.journal.titleEuropean Journal of Clinical Nutrition*
dc.page.initial1733
dc.page.final1739
dc.relation.projectIDBasque Government, Health Department [2018111095]; FEDER, the Spanish Federation for Rare Diseases [FI18053]
dc.relation.publisherversionhttps://www.nature.com/articles/s41430-022-01178-3.pdfes
dc.rights.accessRightsopenAccess
dc.subject.keywordAS Santiagoes
dc.subject.keywordCHUSes
dc.subject.keywordIDISes
dc.typefidesArtículo Científico (incluye Original, Original breve, Revisión Sistemática y Meta-análisis)es
dc.typesophosArtículo Originales
dc.volume.number76


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución 4.0 Internacional